Add-On Benefits of Amlodipine and Thiazide in Nondiabetic Chronic Kidney Disease Stage 1/2 Patients Treated with Valsartan

Publisher： Karger

E-ISSN： 1423-0143|32|1|51-58

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.32, Iss.1, 2009-03, pp. : 51-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Carvedilol as Third-Line Add-On Therapy on Blood Pressure and Glucose Metabolism in Type 2 Diabetic Patients with Chronic Renal Disease Stage 3 and Above

By  

Kidney and Blood Pressure Research, Vol. 36, Iss. 1, 2012-10 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Dyslipidemia in Patients with Chronic and End-Stage Kidney Disease

By  

Cardiorenal Medicine, Vol. 3, Iss. 3, 2013-07 ,pp. : 165-177

Karger

Access to resources Recommend Favorite

Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study

By  

American Journal of Nephrology, Vol. 42, Iss. 5, 2015-0 ,pp. : 351-360

Karger

Access to resources Recommend Favorite

Effect of Pitavastatin on Urinary Liver-Type Fatty-Acid-Binding Protein in Patients with Nondiabetic Mild Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 26, Iss. 1, 2006-04 ,pp. : 82-86

Karger

Access to resources Recommend Favorite

The Effect of N-Acetylcysteine on Proteinuria and Markers of Tubular Injury in Non-Diabetic Patients with Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 31, Iss. 6, 2008-12 ,pp. : 404-410

Karger

Access to resources Recommend Favorite